BBIO — BridgeBio Pharma, Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
8
all time
Members · 12m
1
5 buys · 1 sells · by trade date
Latest filing
10-12
2026-10-12
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
0
every row filed inside 45 days
13F holders
433
all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29

On Signals

ACTIVE HITS NAMING BBIO · NEWEST FILED FIRST · EVERY HIT CARRIES ITS RECEIPTSignals ↗
Active signal hits naming BBIO, newest filed first
KindWhoTraded → FiledSizeSrc
a disclosed trade in an issuer whose sector falls within a committee the member sat on as of the trade date (versioned mapping; membership dated) — context only: no legal, ethical, or causal conflict is established or impliedCisnerosTraded → Filed +13d$1.0K–$15.0K

1–1 of 1 line · 1 hit · each kind word opens its exact rule · every hit is in signals.v1.json.

COMMITTEE: Context, not an allegation.

Congress 8Institutional 433

Congress · disclosure timeline

By trade date · 24 months · 8 rows ▲ buy, ▼ sell; height = lower bound (log scale); ringed = on Signals. Trade date, not filing date — the filing lag is in the table below.

8 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M; 1 ringed mark is a line of the Signals row above, pinned in the table below.

Members active in BBIO

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing BBIO in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Gilbert Ray Cisneros, Jr. D–CA-316−$10.0K to $74.0K2

1 member

Congressional disclosures

Signals rows first, then newestAll 8 rows ↗
Latest congressional filings mentioning BBIO, the rows on Signals first
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2026-10-12Gilbert Ray Cisneros, Jr. D–CA-31 On SignalsSELL partial (partial sale)Traded 09-29 +13d$1K–$15K
2026-06-08Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 05-11 +28d$1K–$15K
2026-05-08Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 04-29 +9d$1K–$15K
2026-04-07Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 03-19 +19d$1K–$15K
2026-04-07Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 03-18 +20d$1K–$15K
2026-04-07Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 03-03 +35d$1K–$15K
2025-10-10Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 09-22 +18d$1K–$15K
2025-09-12Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 08-08 +35d$1K–$15K

13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only

Top institutional holders of BBIO for quarter 2026-03-31, 1–25 of 433 holders
#FilerValueSecuritiesFlagsderived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§
1BlackRock, Inc.$1.1B1
derived ·§ EDGAR ↗
2Kohlberg Kravis Roberts & Co. L.P.$985M1
derived ·§ EDGAR ↗
3Janus Henderson Group Ltd.$979M1
derived ·§ EDGAR ↗
4VIKING GLOBAL INVESTORS LP$879M1
derived ·§ EDGAR ↗
5FARALLON CAPITAL MANAGEMENT, L.L.C.$695M1
derived ·§ EDGAR ↗
6VANGUARD PORTFOLIO MANAGEMENT LLC$600M1
derived ·§ EDGAR ↗
7VANGUARD CAPITAL MANAGEMENT LLC$576M1
derived ·§ EDGAR ↗
8GEODE CAPITAL MANAGEMENT, LLC$372M1
derived ·§ EDGAR ↗
9STATE STREET CORP$366M1
derived ·§ EDGAR ↗
10Invesco Ltd.$341M1
derived ·§ EDGAR ↗
11Frazier Life Sciences Management, L.P.$256M1
derived ·§ EDGAR ↗
12CITADEL ADVISORS LLC$236M1
derived ·§ EDGAR ↗
13TWO SIGMA INVESTMENTS, LP$232M1
derived ·§ EDGAR ↗
14D. E. Shaw & Co., Inc.$189M1
derived ·§ EDGAR ↗
15Polar Capital Holdings Plc$187M1
derived ·§ EDGAR ↗
16WELLINGTON MANAGEMENT GROUP LLP$184M1
derived ·§ EDGAR ↗
17FRANKLIN RESOURCES INC$181M1
derived ·§ EDGAR ↗
18FMR LLC$174M1
derived ·§ EDGAR ↗
19UBS Group AG$151M1
derived ·§ EDGAR ↗
20MANUFACTURERS LIFE INSURANCE COMPANY, THE$147M1
derived ·§ EDGAR ↗
21CHARLES SCHWAB INVESTMENT MANAGEMENT INC$147M1
derived ·§ EDGAR ↗
22ALLIANCEBERNSTEIN L.P.$146M1
derived ·§ EDGAR ↗
23MORGAN STANLEY$139M1
derived ·§ EDGAR ↗
24SC US (TTGP), LTD.$138M1
derived ·§ EDGAR ↗
25JANE STREET GROUP, LLC$131M1
derived ·§ EDGAR ↗
Show all 433 holders
Truncated by Public Filings. All 372 13F filers reporting this share class are listed. Method ↗

Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.

Congress ↔ notable managers · BBIO

Congress · last 90 days

Buyers
0 — —
Sellers
1 Gilbert Ray Cisneros, Jr. D–CA-31 $1K–$15K

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers · quarter ended 2026-03-31

Adding
1 Bridgewater Associates $19.3M held
Trimming
1 Viking Global Investors $879M held

by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · BRIDGEBIO PHARMA INC

Merged timeline of congressional filings and notable-manager moves on BBIO
DateWhoChangeSize
2026-10-12Gilbert Ray Cisneros, Jr. CongressSELL$1K–$15K
2026-05-15Bridgewater Associates 13FADD+216,287 sh
2026-05-15Viking Global Investors 13FTRIM−2,551,500 sh

3 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)5 buy / 1 sell
Congress net ($ bound)−$10.0K to $74.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.